CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Pooled Analysis of Bleeding, Major Adverse Cardiovascular Events, and All-Cause Mortality in Clinical Trials of Time-Constrained Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective Acute Aortic Syndrome Revisited: JACC State-of-the-Art Review Percutaneous coronary intervention in left main coronary artery disease: the 13th consensus document from the European Bifurcation Club Revascularization of left main coronary artery Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease : A Special Report From the American Heart Association and American College of Cardiology 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Benefit-risk profile of extended dual antiplatelet therapy beyond 1 year in patients with high risk of ischemic or bleeding events after PCI Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction: From the COMPASS Trial
|<<... 130 131 132 133 134 135 136 ...>>|

Review Article2018 Oct;8(5):630-646.

JOURNAL：Cardiovasc Diagn Ther. Article Link

The optimal duration of dual antiplatelet therapy after coronary stent implantation: to go too far is as bad as to fall short

Costa F, Valgimigli M. Keywords: DAPT duration; Dual antiplatelet therapy (DAPT); PRECISE-DAPT; bleeding; coronary stenting

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top